• 1
    Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999; 341: 124955.
  • 2
    Christiansen P, Steiniche T, Vesterby A, Mosekilde L, Hessov I, Melsen F. Primary hyperparathyroidism: iliac crest trabecular bone volume, structure, remodeling, and balance evaluated by histomorphometric methods. Bone 1992; 13: 4149.
  • 3
    Vestergaard P, Mollerup CL, Frøkjær VG, Christiansen P, Blichert-Toft M, Mosekilde L. Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ 2000; 321: 598602.
  • 4
    Silverberg SJ, Gartenberg F, Jacobs TP et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 1995; 80: 72934.
  • 5
    Christiansen P, Steiniche T, Brixen K et al. Primary hyperparathyroidism: effect of parathyroidectomy on regional bone mineral density in Danish patients – a three year follow-up study. Bone 1999; 25: 58995.
  • 6
    Leppla DC, Snyder W, Pak CY. Sequential changes in bone density before and after parathyroidectomy in primary hyperparathyroidism. Invest Radiol 1982; 17: 6046.
  • 7
    Rao D, Phillips ER, Divine GW, Talpos GB. Randomized controlled trial of surgery vs. no-surgery in patients with mild asymptomatic primary hyperparathyroidism: final report. J Bone Mineral Res 2000; 15 (Suppl. 1): S164 (Abstract).
  • 8
    Khosla S, Melton LJ, III, Wermers RA, Crowson CS, O'Fallon WM, Riggs BL. Primary hyperparathyroidism and the risk of fracture: a population-based study. J Bone Mineral Res 1999; 14: 17007.
  • 9
    Peacock M, Horsman A, Aaron JE, Marshall DH, Selby PL, Simpson M. The role of parathyroid hormone in bone loss. In: ChristiansenC, ArnaudCD, NordinBEC, ParfittAM, PeckWA, RiggsBL, eds. Osteoporosis. Glostrup: Department of Clinical Chemistry, Glostrup Hospital, 1984; 4637.
  • 10
    Larsson K, Ljunghall S, Krusemo UB, Naessen T, Lindh E, Persson I. The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years. J Intern Med 1993; 234: 58593.
  • 11
    Frank L. Epidemiology. When an entire country is a cohort. Science 2000; 287: 23989.
  • 12
    Andersen TF, Madsen M, Jørgensen J, Mellemkjær L, Olsen JH. The Danish National Hospital Register. Danish Med Bull 1999; 46: 2638.
  • 13
    Klotzbuecher CM, Ross PD, Landsman PB, Abbott TA, III, Berger M. Patients with prior fractures have an increased risk of future fractures: a summary of the litterature and statistical synthesis. J Bone Miner Res 2000; 15: 72139.
  • 14
    Black DM, Cummings SR, Kerpf DB et al. Randomised trial of the effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 1996; 348: 153541.
  • 15
    Hedback G, Oden A, Tisell LE. Parathyroid adenoma weight and the risk of death after treatment for primary hyperparathyroidism. Surgery 1995; 117: 1349.
  • 16
    Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312: 12549.
  • 17
    Christiansen P, Steiniche T, Brixen K et al. Primary hyperparathyroidism: whole-body bone mineral density in surgically treated Danish patients: a three-year follow-up study. Bone 1999; 25: 597602.
  • 18
    Elvius M, Lagrelius A, Nygren A, Alveryd A, Christensson TAT, Nordenström J. Seventeen years follow-up study of bone mass in patients with mild asymptomatic hyperparathyroidism some of whom were operated on. Eur J Surg 1996; 161: 8639.
  • 19
    Garnero P, Sornay-Rendu E, Duboeuf F, Delmas PD. Markers of bone turnover predict postmenopausal forearm bone loss over 4 years: the OFELY study. J Bone Mineral Res 1999; 14: 161421.